An unusually bold stand by doctors at the Memorial Sloan-Kettering Cancer Center in New York has forced a big drug company to reduce the cost of an overpriced drug for treating colorectal cancer that was no better than a cheaper competitor and did almost nothing to extend a patient’s life. It is a heartening sign that alert and aggressive physicians can potentially play a major role in helping to reduce the escalating costs of health care for treatments of marginal value.
To continue reading, click here.





Some of the most deplorable & dishonest actions by the pharmaceutical industry took place with the advent of anti-HIV drugs. In many instances, when recovering research costs were claimed as a reason for the high prices; it came to light that the research had actually been done in US Army laboratories. With a drug called AZT, which was an older & largely inefficient anti-cancer drug which had been shelved; when it was found to be effective when used with other anti-HIV drugs; the cost quadrupled.